18 Systemic immune profiling of advanced biliary tract cancer patients defines altered cytokines and immune cell populations
Main Authors: | Yuan Liu, Gregory Lesinski, Mark Yarchoan, Subir Goyal, Helen Chen, Amanda Ruggieri, Shishir Maithel, Bassel El-rayes, Nilofer Azad, Brian Olson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Immunotherapy for the treatment of biliary tract cancer: an evolving landscape
by: Helen Catherine Wilbur, et al.
Published: (2024-03-01) -
MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity.
by: Mark Yarchoan, et al.
Published: (2019-01-01) -
330 Investigating the clinical safety, efficacy, and immune modulation of combined XL888 and pembrolizumab in metastatic gastrointestinal malignancies
by: Mohammad Zaidi, et al.
Published: (2020-11-01) -
1507 The Galectin-9-Tim-3 pathway is a novel checkpoint target for patients with biliary tract cancer
by: Yuan Liu, et al.
Published: (2023-11-01) -
The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer
by: Mitsuru Sugimoto, et al.
Published: (2017-08-01)